Tesamorelin

Description

Trigger Growth. Target Fat. Study Metabolic Precision.

Tesamorelin is a synthetic Growth Hormone-Releasing Hormone (GHRH) analog, studied for its ability to stimulate endogenous GH release and influence visceral fat metabolism, insulin sensitivity, and lean tissue regulation. Designed with a stabilizing trans-3-hexenoic acid group, Tesamorelin has enhanced resistance to enzymatic breakdown—allowing for longer activity and consistent GH pulse amplification in research models.

Researchers use Tesamorelin to investigate:

⚡️ Pulsatile GH release and IGF-1 pathway activation
⚡️ Reduction of visceral adipose tissue (VAT)
⚡️ Glucose metabolism and insulin response modulation
⚡️ GH-related body composition and endocrine feedback loops

Tesamorelin is a top choice for labs modeling metabolic dysfunction, age-related GH decline, and lean-to-fat mass shifts, offering a cleaner, GH-axis-driven approach to body recomposition studies.

Product Details:

Synonyms: Egrifta (brand name), GHRH(1–44) analog

CAS Number: 218949-48-5

Molecular Formula: C221H366N72O67S

Molecular Weight: ~5135.9 g/mol

Form: Lyophilized peptide (Receptor Grade)

Storage: Store in a cool, dry place. Refrigerate or freeze for long-term use. Avoid repeated freeze-thaw cycles.

⚠️ Research Use Only

Tesamorelin is sold strictly for laboratory research use only. It is not for human consumption or therapeutic use, and is not FDA-approved for research use outside qualified settings. This compound is not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm you are a qualified researcher or lab professional using it under applicable laws and protocols.